Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of anastrozole in women with asymptomatic müllerian cancer.
del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Among authors: roche m. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.
Communicating genetic risk: pros, cons, and counsel.
Penson RT, Seiden MV, Shannon KM, Lubratovich ML, Roche M, Chabner BA, Lynch TJ Jr. Penson RT, et al. Among authors: roche m. Oncologist. 2000;5(2):152-61. doi: 10.1634/theoncologist.5-2-152. Oncologist. 2000. PMID: 10794806 Free article.
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.
Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S, Roche M, Colella T, Lee H, Seiden MV; Gynecologic Oncology Research Program at Dana Farber/Partners Cancer Care; Dana Farber-Harvard Cancer Care. Matulonis U, et al. Among authors: roche m. Gynecol Oncol. 2003 Nov;91(2):293-8. doi: 10.1016/s0090-8258(03)00496-7. Gynecol Oncol. 2003. PMID: 14599858 Clinical Trial.
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.
Penson RT, Campos SM, Seiden MV, Krasner C, Fuller AF Jr, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare. Penson RT, et al. Among authors: roche m. Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1035-41. doi: 10.1111/j.1525-1438.2005.00482.x. Int J Gynecol Cancer. 2005. PMID: 16343179 Free article. Clinical Trial.
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.
Matulonis UA, Campos S, Krasner CN, Duska LR, Penson RT, Falke R, Roche M, Smith LM, Lee H, Seiden MV; Dana-Farber/Partners CancerCare and Harvard Vanguard Medical Associates. Matulonis UA, et al. Among authors: roche m. Gynecol Oncol. 2006 Nov;103(2):575-80. doi: 10.1016/j.ygyno.2006.04.017. Epub 2006 Jun 23. Gynecol Oncol. 2006. PMID: 16806439 Clinical Trial.
1,270 results